Premium
Rapid infliximab infusions are generally well‐tolerated in children with inflammatory bowel disease
Author(s) -
Glover Caitlin,
Phuong Linny,
Hinds Rupert
Publication year - 2017
Publication title -
journal of paediatrics and child health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.631
H-Index - 76
eISSN - 1440-1754
pISSN - 1034-4810
DOI - 10.1111/jpc.13384
Subject(s) - medicine , infliximab , tolerability , adverse effect , inflammatory bowel disease , retrospective cohort study , disease , gastroenterology , surgery
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom